TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+2.99%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$671M
AUM Growth
+$671M
(-2.5%)
Cap. Flow
+$89.1M
Cap. Flow
% of AUM
13.28%
Top 10 Holdings %
Top 10 Hldgs %
38.66%
Holding
127
New
38
Increased
28
Reduced
16
Closed
24
Top Buys
| 1 |
Novo Nordisk
NVO
|
$21.5M |
| 2 |
Evolus
EOLS
|
$20.2M |
| 3 |
BLUE
bluebird bio
BLUE
|
$16.7M |
| 4 |
FLG
Flagstar Financial, Inc.
FLG
|
$14.5M |
| 5 |
Adicet Bio
ACET
|
$11.1M |
Top Sells
| 1 |
AnaptysBio
ANAB
|
$13M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$12M |
| 3 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$8.9M |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$6.72M |
| 5 |
Cytokinetics
CYTK
|
$5.04M |
Sector Composition
| 1 | Healthcare | 91.26% |
| 2 | Financials | 6.75% |
| 3 | Real Estate | 0.31% |
| 4 | Consumer Discretionary | 0.05% |